Sign In to Follow Application
View All Documents & Correspondence

"Excitatory Amino Acid Receptor Antagonists"

Abstract: The present invention provides novel compounds of Formula (I) and (I(a)), or the pharmaceutically acceptable salt thereof; methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine, comprising administering a compound of Formula (I) or Formula (I(a)); and processes for preparing compounds of Formula (I) or Formula (I(a)).

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
05 February 2007
Publication Number
36/2008
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
LILLY CORPORATE CENTER, INDIANAPOLIS, IN 46285

Inventors

1. ARNOLD, MACKLIN, BRIAN
6667, NORTH LAWSON WAY, MORGANTOWN, IN 46160 (US)
2. BLEISCH, THOMAS JOHN
318 SCARBOROUGH WAY, NOBLESVILLE, IN 46060
3. CASTANO MONSANET, ANA, MARIA
Lilly S.A., AVENIDA DE LA INDUSTRIA 30, E-28100 ALCOBENDAS (ES)
4. DOMINGUEZ-MANZANARES, ESTEBAN
Lilly S.A., AVENIDA DE LA INDUSTRIA 30, E-28100 ALCOBENDAS (ES)
5. ESCRIBANO, ANA, MARIA
Lilly S.A., AVENIDA DE LA INDUSTRIA 30, E-28100 ALCOBENDAS (ES)
6. MARTINEZ PEREZ, JOSE, ANTONIA
Lilly S.A., AVENIDA DE LA INDUSTRIA 30, E-28100 ALCOBENDAS (ES)
7. MATEO HERRANZ, ANA, ISABEL
Lilly S.A., AVENIDA DE LA INDUSTRIA 30, E-28100 ALCOBENDAS (ES)
8. ORNSTEIN, PAUL, LESLIE
10441 BOSAHAN COURT, CARMEL, IN 46032
9. WINTER, MARK, ALAN
4733 KESSLER VIEW DRIVE, INDIANAPOLIS, IN 46220
10. MAY, SCOTT, ALLAN
10176 BOOTHAM CLOSE, NOBLESVILLE, IN 46060
11. RATZ, ANDREW, MICHAEL
225 SOUTHWIND WAY, GREENWOOD IN 46162
12. WILSON, THOMAS, MICHAEL
1193 GREENLAWN STREET, SPEEDWAY, IN 46224

Specification

The present invention provides novel compounds of Formula (I) and (I(a)), or the pharmaceutically acceptable salt thereof; methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine, comprising administering a compound of Formula (I) or Formula (I(a)); and processes for preparing compounds of Formula (I) or Formula (I(a)).

Documents

Application Documents

# Name Date
1 387-KOLNP-2007-FIRST EXAMINATION REPORT-1-1_.pdf 2018-10-11
1 387-KOLNP-2007-FORM 13.pdf 2011-10-06
2 387-KOLNP-2007-ABANDONED LETTER.pdf 2016-12-16
2 387-KOLNP-2007-CORRESPONDENCE.pdf 2011-10-06
3 387-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2016-12-16
3 0387-kolnp-2007 form-5.pdf 2011-10-06
4 387-KOLNP-2007-FIREST EXAMINATION REPORT.pdf 2016-10-07
4 0387-kolnp-2007 form-3.pdf 2011-10-06
5 387-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
5 0387-kolnp-2007 form-2.pdf 2011-10-06
6 0387-kolnp-2007 form-1.pdf 2011-10-06
6 00387-kolnp-2007-assignment.pdf 2011-10-06
7 0387-kolnp-2007 description(complete).pdf 2011-10-06
7 00387-kolnp-2007-correspondence-1.1.pdf 2011-10-06
8 0387-kolnp-2007 correspondence others.pdf 2011-10-06
8 00387-kolnp-2007-form 18.pdf 2011-10-06
9 0387-kolnp-2007 abstract.pdf 2011-10-06
9 0387-kolnp-2007 claims.pdf 2011-10-06
10 0387-kolnp-2007 abstract.pdf 2011-10-06
10 0387-kolnp-2007 claims.pdf 2011-10-06
11 00387-kolnp-2007-form 18.pdf 2011-10-06
11 0387-kolnp-2007 correspondence others.pdf 2011-10-06
12 00387-kolnp-2007-correspondence-1.1.pdf 2011-10-06
12 0387-kolnp-2007 description(complete).pdf 2011-10-06
13 00387-kolnp-2007-assignment.pdf 2011-10-06
13 0387-kolnp-2007 form-1.pdf 2011-10-06
14 0387-kolnp-2007 form-2.pdf 2011-10-06
14 387-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
15 0387-kolnp-2007 form-3.pdf 2011-10-06
15 387-KOLNP-2007-FIREST EXAMINATION REPORT.pdf 2016-10-07
16 0387-kolnp-2007 form-5.pdf 2011-10-06
16 387-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2016-12-16
17 387-KOLNP-2007-ABANDONED LETTER.pdf 2016-12-16
17 387-KOLNP-2007-CORRESPONDENCE.pdf 2011-10-06
18 387-KOLNP-2007-FORM 13.pdf 2011-10-06
18 387-KOLNP-2007-FIRST EXAMINATION REPORT-1-1_.pdf 2018-10-11